FIELD: medicine. SUBSTANCE: method involves applying Mexidol (2-ethyl-6-methyl-3-oxypyridine succinate). EFFECT: enhanced effectiveness of hypoglycemic and hypolipidemic preparations action; lower frequency of cases with adverse side effects. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENTS WITH DIABETES MELLITUS | 1996 |
|
RU2134109C1 |
ANTIBACTERIAL AGENT | 1999 |
|
RU2157686C1 |
METHOD FOR TREATING PREDIABETES IN PERSONS WITH EXTERNAL EATING BEHAVIOR | 2022 |
|
RU2805361C1 |
METHOD FOR COMPLEX TREATMENT OF METABOLIC SYNDROME | 2015 |
|
RU2616125C1 |
METHOD OF HUMAN ORGANISM ADAPTATION IN PATHOLOGICAL PROCESSES ACCOMPANYING WITH METABOLIC DISORDERS | 1996 |
|
RU2132192C1 |
METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
METHOD OF TREATING METABOLIC SYNDROME IN EMOTIOGENIC TYPE OF EATING BEHAVIOUR | 2015 |
|
RU2591811C1 |
METHOD OF TREATING METABOLIC SYNDROME | 2015 |
|
RU2583944C1 |
METHOD FOR SURGICAL TREATMENT OF DIABETES MELLITUS | 1996 |
|
RU2100966C1 |
Authors
Dates
2000-11-10—Published
1999-11-10—Filed